Alzheimer's disease (AD) is a major cause of dementia in older adults and is fast becoming
a major societal and economic burden due to an increase in life expectancy. Age seems to …

Despite recent FDA approval of anti-amyloid antibodies for Alzheimer's Disease, strategies
that target early molecular mechanisms and could delay or change the disease trajectory …

Amyloid-beta (Aβ) peptides have a role in the pathogenesis of Alzheimer's disease (AD) and
are thought to promote oxidative stress, endoplasmic reticulum (ER) stress and …

Common pathophysiological mechanisms have emerged for different neurological and
neuropsychiatric conditions. In particular, mechanisms of oxidative stress, immuno …

Human herpesviruses (HHVs) have been implicated as possible risk factors in Alzheimer's
disease (AD) pathogenesis. Persistent lifelong HHVs infections may directly or indirectly …

Extremely low gestational age neonates (ELGANs) are born in a relatively hyperoxic
environment with weak antioxidant defenses, placing them at high risk for mitochondrial …

Background Obesity is a complex condition that influences several organ systems and
physiologic systems. Obesity (OB) is closely linked to Alzheimer's disease (AD). However …

Aging is the main risk factor for sporadic Alzheimer's disease (AD), which is characterized by
the cerebral deposition of β-amyloid peptides (Aβ) and cognitive decline. Mitochondrial …

Neurodegenerative diseases (Alzheimer's disease, Parkinson's disease, Huntington's
disease, and others) and cancer, seemingly disparate in their etiology and manifestation …

Neurodegenerative diseases (NDs) are a significant global health concern, primarily
affecting middle and older populations. Recently, there has been growing interest in herbal …